Drug Approval | November 15, 2025
Zydus receives final approval from USFDA for Leuprolide Acetate injection
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
The investment in land is Rs. 19.85 crore
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Subscribe To Our Newsletter & Stay Updated
